Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients

SIMPLE SUMMARY: Unlike the neutrophil/lymphocyte ratio (NLR), more complex complete blood count (CBC)-based systemic immune-inflammation cancer biomarkers have recently been proposed, such as the pan-immune-inflammation value (PIV). We aimed to assess both NLR and PIV in cutaneous melanoma (CM) pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambichler, Thilo, Stang, Andreas, Mansour, Rita, Scheel, Christina H., Nick, Celine, Abu Rached, Nessr, Becker, Jürgen C., Susok, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496745/
https://www.ncbi.nlm.nih.gov/pubmed/36139570
http://dx.doi.org/10.3390/cancers14184410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496745/
https://www.ncbi.nlm.nih.gov/pubmed/36139570
http://dx.doi.org/10.3390/cancers14184410

Ejemplares similares